Stem Cell Update Presented at MS Conference for Healthcare Professionals

Cooperative Meeting of CMSC & ACTRIMS, May 28-31, 2014, Dallas, TX 

Hackensack, NJ — (SBWIRE) — 05/22/2014 — Current information on stem cells and multiple sclerosis will be the topic of discussion at the “Meet the Professor” dinner taking place May 28th at the 2014 Cooperative Meeting of CMSC (Consortium of Multiple Sclerosis Centers) & ACTRIMS® (Americas Committee for Treatment and Research in Multiple Scle Featuring Dr. Mark Freedman, Professor of Neurology at the University of Ottawa and the senior scientist at the Ottawa Hospital Research Institute, this unique educational opportunity will provide insight on the various types of stem cells, the trials and tribulations taking place, as well as where the stem cells field is heading in terms of treating MS in the next 5 years.

“There is much being written and discussed about stem cells and this session will help healthcare professionals be better informed when discussing the topic with their patients,” said Dr. Freedman. “I will be discussing the many obstacles that still need to be overcome in terms of ensuring the safety as well as the efficacy of such a treatment.”

The “Meet the Professor” is part of a robust educational agenda that includes lectures, panel discussions, poster presentations, and continuing education programs for physicians, nurses, pharmacists, and psychologists.

The Cooperative Meeting of CMSC & ACTRIMS, May 28-31, at the Hilton Anatole in Dallas, TX, opens with Dr. Stephen Miller discussing “Tolerance Directed Immunotherapies Employing Biodegradable PLG Nanoparticles –The Future of MS Treatment. “

Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews